Massachusetts Financial Services’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.7M | Sell |
|
|||||
|
2025
Q2 | $20.4M | Sell |
|
|||||
|
2025
Q1 | $25M | Sell |
|
|||||
|
2024
Q4 | $28.5M | Buy |
|
|||||
|
2024
Q3 | $26.4M | Buy |
|
|||||
|
2024
Q2 | $15.7M | Buy |
|
|||||
|
2024
Q1 | $17M | Sell |
|
|||||
|
2023
Q4 | $16.4M | Buy |
|
|||||
|
2023
Q3 | $16.7M | Buy |
|
|||||
|
2023
Q2 | $17.9M | Buy |
|
|||||
|
2023
Q1 | $13.4M | Buy |
|
|||||
|
2022
Q4 | $18.7M | Sell |
|
|||||
|
2022
Q3 | $18.4M | Buy |
|
|||||
|
2022
Q2 | $18.9M | Sell |
|
|||||
|
2022
Q1 | $19M | Sell |
|
|||||
|
2021
Q4 | $23.9M | Sell |
|
|||||
|
2021
Q3 | $25.6M | Sell |
|
|||||
|
2021
Q2 | $19.1M | Buy |
|
|||||
|
2021
Q1 | $20M | Buy |
|
|||||
|
2020
Q4 | $18.6M | Buy |
|
|||||
|
2020
Q3 | $11.2M | Buy |
|